Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effective Dose of Remimazolam for Loss of Consciousness in Children: A Prospective Dose Finding Study

NCT05975255 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05975255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effective Dose of Remimazolam for Loss of Consciousness in Children: A Prospective Dose Finding Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 16, 2023
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect